Engineering the Future of Injection
Smaller. Safer. Smarter.
xJect is an ultra-compact prefilled syringe delivering massive savings, unmatched security and expands global access to critical medications.
COVID-19
Revealing the Importance of
Supply Chain Efficiency
The Wake-Up Call
In late 2019, a novel virus emerged in Wuhan, China. Within weeks, it had crossed borders. Within months, it had spread across the globe. In March 2020, the World Health Organization declared COVID-19 a global pandemic.
Healthcare systems faced an unprecedented challenge. Hospitals filled beyond capacity. At times, people were buried in mass graves. Governments raced to secure vaccines and critical medical supplies. Entire economies slowed or stopped.
But the crisis exposed something deeper.
It revealed that global healthcare delivery was not limited by science alone. It was limited by logistics.
Vaccines and injectable medicines could not reach people fast enough, not because they could not be produced, but because they could not be stored, transported, and distributed efficiently. Cold storage space was scarce. Shipping capacity was constrained. Every cubic inch mattered.
The physical size and design of delivery devices became a critical factor.
This moment revealed a fundamental truth. Efficiency in drug delivery is not just a matter of convenience. It is a matter of global resilience.
xJect was created with this reality in mind.
By reducing the size, complexity, and material footprint of prefilled syringes, xJect enables more efficient storage, transportation, and delivery of life-saving medications. It is a design approach built not only for today’s healthcare systems, but for the global challenges of tomorrow.
Case Study
Pandemic Lessons: Why Device Efficiency Matters
The COVID-19 pandemic exposed critical weaknesses in global healthcare supply chains. Vaccine distribution was limited not only by manufacturing capacity, but by storage space, shipping volume, and logistics efficiency.
Traditional prefilled syringes occupy significantly more volume than the medication they deliver, increasing cold chain requirements, transportation costs, and material usage.
xJect addresses these challenges with an ultra-compact, fully integrated design that reduces device size by up to 40%. This enables more efficient storage, reduces packaging volume, and improves distribution efficiency.
By optimizing the physical footprint of drug delivery, xJect helps healthcare systems store more doses, ship more efficiently, and deliver medication more reliably.
What COVID actually disrupted
COVID exposed structural inefficiencies that were already present, especially in injectable drug delivery.
1. Packaging and
shipping inefficiency
became a major
bottleneck
Prefilled syringes are extremely volume-inefficient. They contain far more air and packaging than drug volume.
During COVID:
-
Air freight capacity dropped sharply
-
Shipping container costs increased 4–8×
-
Cold chain storage space became scarce
-
Vaccine distribution became constrained by storage and logistics, not manufacturing alone
This meant logistics efficiency suddenly became as important as manufacturing capacity.
2. Cold chain storage
became a critical
limitation
Vaccines like those from Pfizer and Moderna required strict temperature control.
Hospitals, clinics, and distribution centers faced shortages of:
-
Refrigerated storage space
-
Transport containers
-
Ultra-cold freezers
The physical size of delivery devices became a limiting factor.
A smaller syringe directly increases storage density.
3. Material shortages
increased device costs
Global shortages occurred in:
-
Medical-grade plastics
-
Glass barrels
-
Rubber components
-
Sterile packaging materials
A smaller, integrated device reduces material usage and packaging burden.
4. Dead space and
dose waste became
visible at global scale
Even small inefficiencies became enormous when billions of doses were involved.
For example:
-
1–5% dose loss across billions of doses = tens of millions of lost doses
-
Low dead-space syringes became strategically important
This is directly relevant to xJect’s dose efficiency and leak-safe design.
Get in touch
Get the latest on xJect technology and partnership opportunities.